Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Editorial policy

Last updated: 2026-03-02

Primary-source citationsEditorial / revenue separatedNamed-reviewer policy

glpzoom publishes editorial content about telehealth services, prescription medications, and treatment options for weight management, sexual health, hair loss, and other consumer health categories. Our goal is to help readers make informed decisions. This is the process we use.

Who writes our content

Editorial content is produced by the glpzoom editorial team. We are not clinicians and we do not give medical advice; our job is to summarize current evidence, label every source, and make the information readers need to choose a program accessible. Where an individual writer is credited by name, that byline reflects a real person.

How we review our content

Clinical content is reviewed against primary sources — FDA prescribing information, peer-reviewed trial publications, and specialty-society guidelines — before publication and whenever those sources change. The exact sources we check against, tier by tier, are documented on our how we review page.

When a page has been reviewed by a named, licensed clinician, that page shows the reviewer's name, credentials, and a licensure-verification link. We attribute a review to a named person only when a real, verifiable clinician has signed off; otherwise the review is attributed to the glpzoom editorial team at the organization level. We never publish fabricated reviewer identities or credentials.

Review cadence

Each clinical page shows a “last reviewed” date. That date means the content was checked against the sources above for the current cycle. Pages that summarize rapidly changing information — pricing, formulary status, recall notices — are re-checked more frequently and dated explicitly. The date is a sourcing claim, not a claim that a clinician personally re-read that page on that day.

How we cite evidence

Where we make a specific clinical claim (e.g., "~15% body weight loss in STEP-1 trial"), we cite the underlying source — typically the FDA prescribing information, a peer-reviewed clinical trial publication, or a guideline from a major medical body. We avoid citing secondary or tertiary sources for clinical facts; the goal is to give readers a path to verify our claims.

Separation of editorial and revenue

glpzoom earns affiliate revenue when readers click through and become customers of telehealth services we review (see our affiliate disclosure). To protect editorial integrity:

Corrections and updates

We correct factual errors as soon as we identify them. When we make a substantive correction to a published page, we update the "Last reviewed" date and, for material corrections (changing an answer, withdrawing a recommendation, fixing a price or dose), we add a dated correction note at the bottom of the page. Minor typos, grammar fixes, and stylistic updates do not trigger correction notes.

See our corrections policy for the full process and to submit a correction.

What we don't do

Contact

Editorial questions, corrections, or concerns: [email protected].

We may earn a commission when you click links to partners. Affiliate disclosure.